We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.02B
AUM Growth
+$915M
Cap. Flow
+$807M
Cap. Flow %
16.08%
Top 10 Hldgs %
23.32%
Holding
1,875
New
492
Increased
516
Reduced
411
Closed
433

Sector Composition

Rank Sector Weight
1 Technology 19.46%
2 Healthcare 13.87%
3 Consumer Discretionary 11.88%
4 Industrials 11.63%
5 Energy 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMTS icon
1426
CPI Card Group
PMTS
$250M
$65K ﹤0.01%
4,596
+2,155
+88% +$30.8K
QUMU
1427
DELISTED
Qumu Corp.
QUMU
$63K ﹤0.01%
21,536
CGEN icon
1428
Compugen
CGEN
$216M
$62K ﹤0.01%
+16,293
New +$67.8K
IMUX icon
1429
Immunic
IMUX
$191M
$49K ﹤0.01%
+42
New +$56.1K
SYRE icon
1430
Spyre Therapeutics
SYRE
$8.43B
$48K ﹤0.01%
+496
New +$68.6K
ECYT
1431
DELISTED
Endocyte, Inc. Common Stock
ECYT
$45K ﹤0.01%
29,927
-90,632
-75% -$195K
ANDAR
1432
DELISTED
Andina Acquisition Corp. II Right
ANDAR
$43K ﹤0.01%
98,000
XNET
1433
Xunlei
XNET
$346M
$37K ﹤0.01%
+11,369
New +$40.5K
GPL
1434
DELISTED
Great Panther Mining Limited
GPL
$28K ﹤0.01%
2,160
TTNP
1435
DELISTED
Titan Pharmaceuticals
TTNP
$27K ﹤0.01%
+4
New +$37.2K
TOVX icon
1436
Theriva Biologics
TOVX
$10.1M
$23K ﹤0.01%
+5
New +$24.9K
CARM
1437
DELISTED
Carisma Therapeutics
CARM
$22K ﹤0.01%
+691
New +$23K
AMPE
1438
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$18K ﹤0.01%
+116
New +$23.5K
TVIA
1439
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$14K ﹤0.01%
+58,317
New +$21.1K
BPTH
1440
DELISTED
Bio-Path Holdings Inc
BPTH
$9K ﹤0.01%
+6
New +$12.6K
ORIG
1441
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$7K ﹤0.01%
5
ABT icon
1442
Abbott
ABT
$185B
-50,504
Closed -$2.24M
ACN icon
1443
Accenture
ACN
$101B
-11,991
Closed -$1.44M
ADI icon
1444
Analog Devices
ADI
$177B
-52,768
Closed -$4.32M
ADTN icon
1445
Adtran
ADTN
$701M
-14,535
Closed -$302K
AEE icon
1446
Ameren
AEE
$30.3B
-12,848
Closed -$701K
AFG icon
1447
American Financial Group
AFG
$11.8B
-4,617
Closed -$441K
AGCO icon
1448
AGCO
AGCO
$7.26B
-12,666
Closed -$762K
AGIO icon
1449
Agios Pharmaceuticals
AGIO
$1.83B
-13,814
Closed -$807K
AGO icon
1450
Assured Guaranty
AGO
$3.72B
-32,792
Closed -$1.22M

Similar funds

Oxford Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Oxford Asset Management held 1,875 positions worth $5.02B, up 22% from $4.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oxford Asset Management deployed $807M of net new capital in Q2 2017, opening 492 new positions and adding to 516 existing holdings. Its largest new stake was CR Bard Inc.: 511,170 shares worth $162M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $32M trimmed.

  • Oxford Asset Management's largest Q2 2017 buy was CR Bard Inc.: 511,170 shares worth $162M.
  • Oxford Asset Management added most to Rice Energy Inc. in Q2 2017, an estimated $127M increase.
  • Oxford Asset Management's biggest Q2 2017 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $32M.
  • Oxford Asset Management fully exited The WhiteWave Foods Company in Q2 2017, selling an estimated $104M.
  • Oxford Asset Management's ten largest holdings make up 23% of its $5.02B portfolio in Q2 2017.
  • Oxford Asset Management opened 492 new positions and closed 433 in Q2 2017.
  • Oxford Asset Management's portfolio value rose 22% quarter-over-quarter to $5.02B.

Based on Oxford Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.